NCT00695643View on ClinicalTrials.gov

Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis

PHASE3TerminatedINTERVENTIONAL
Enrollment

345

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

November 30, 2011

Study Completion Date

January 31, 2012

Conditions
Diverticulitis
Interventions
DRUG

Mesalazine

3 g per day

DRUG

Placebo

0 g per day

Trial Locations (1)

51103

Evang. Krankenhaus Kalk, Medical department, Cologne

Sponsors
All Listed Sponsors
lead

Dr. Falk Pharma GmbH

INDUSTRY